CNNA.US Cann American Corp

Healthcare Pharmaceuticals USA Stocks
0.0050 USD
Close of Nov 14, 2026
0.0001 0.0080
Market cap
USD 1.31M
P/E
-
P/B
0.00x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Feb 2023.

Is CNNA.US undervalued?

Graham number

The Graham number of Cann American Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cann American Corp fundamental analysis

No fundamental analysis for Cann American Corp yet.

Cann American Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cann American Corp

Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Co…

Full company profile